STAAR Surgical Launches New Visian ICL(TM) Website
Website Provides Critical Information to Consumers and Doctors
MONROVIA, Calif., Nov. 22 /PRNewswire-FirstCall/ -- STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that is has officially launched its new STAAR Visian ICL website at visianinfo.com or www.seebeyondlasik.com. The site is designed to provide doctors and consumers with information and other helpful insights that should be useful in the decision-making process to become users of the ICL.
"The Internet can be a powerful tool to educate both consumers and doctors and we believe our new website will provide easy access to compelling data and resources for our Visian ICL," said David Bailey, President and CEO of STAAR Surgical. "Our website will be a portal through which users can read about Visian ICL advantages over competing technology, peruse clinical data supporting the superior visual outcomes, find a doctor who implants the Visian ICL and review testimonials from patients who have undergone the procedure.
"We are very proud of the website, which is comprehensive and complete with educational video and surgical animations of the ICL procedure," continued Mr. Bailey. "We are focused on providing the support necessary to make the Visian ICL a logical choice for both patients and doctors looking for a new refractive alternative for treating myopia and believe that our new website will be a key component of this strategy. This is the first stage in a phased rollout of improvements to all of our websites, including www.staar.com and our international ones, which will focus on improving website navigation and content."
New Website Features
visianinfo.com or www.seebeyondlasik.com will provide a range of content that STAAR believes will be helpful to doctors and potential patients including:
- What is the Visian ICL?: This portion of the site discusses the
history of eye vision correction, the ICL surgical procedure, the
benefits of the Company's patented Collamer(R) material and the
optimal candidate for the Visian ICL.
- Advantages: Users can read about the conveniences of the Visian ICL
and get a better understanding of why it might be a good choice for
them.
- Visian vs. Others: Doctors and patients can assess how the Visian
ICL favorably stacks up against competing technology.
- Testimonials: In this section users can read about positive first-
hand patient accounts of experiences with the Visian ICL.
- Clinical Results: This section provides highlight statistics from
the three-year Food and Drug Administration clinical trial and
provides a comparison of the Visian ICL to LASIK for the correction
and reduction of moderate to high myopia.
- Locate A Doctor: This section allows potential patients to locate
doctors in their areas who are currently certified to do the Visian
ICL procedure.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL is approved by the FDA for use in treating myopia, has received CE Marking and is approved for sale in 43 countries. Approximately 65,000 ICLs have been sold worldwide. More information is available at www.staar.com.
Contact: Investors, Douglas Sherk, +1-415-896-6820, or Jennifer Beugelmans, +1-646-201-5447, or Media, Jennifer Saunders, +1-646-201-5431, all of EVC Group.
Source: STAAR Surgical Company
CONTACT: Investors, Douglas Sherk, +1-415-896-6820, or Jennifer Beugelmans, +1-646-201-5447; Media, Jennifer Saunders, +1-646-201-5431, all of EVC Group
Web site: www.seebeyondlasik.com/
Web site: http://visianinfo.com/
Web site: www.staar.com/
